This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (307)  • Contact me when this article is cited  Related Content  • Related letter  • Related articles  • Similar articles in JAMA  Topic Collections  • Neurology  • Cerebrovascular Disease  • Stroke  • Women's Health  • Menopause  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

The Women's Health Initiative: A Randomized Trial

Sylvia Wassertheil-Smoller, PhD; Susan Hendrix, DO; Marian Limacher, MD; Gerardo Heiss, MD; Charles Kooperberg, PhD; Alison Baird, MD, PhD, MPH; Theodore Kotchen, MD; J. David Curb, MD; Henry Black, MD; Jacques E. Rossouw, MD; Aaron Aragaki, MS; Monika Safford, MD; Evan Stein, MD, PhD; Somchai Laowattana, MD; W. Jerry Mysiw, MD; for the WHI Investigators

JAMA. 2003;289:2673-2684.

Context  The Women's Health Initiative (WHI) trial of estrogen plus progestin was stopped early because of adverse effects, including an increased risk of stroke in the estrogen plus progestin group.

Objective  To assess the effect of estrogen plus progestin on ischemic and hemorrhagic stroke and in subgroups, and to determine whether the effect of estrogen plus progestin was modified by baseline levels of blood biomarkers.

Design  Multicenter double-blind, placebo-controlled, randomized clinical trial involving 16 608 women aged 50 through 79 years with an average follow-up of 5.6 years. Baseline levels of blood-based markers of inflammation, thrombosis, and lipid levels were measured in the first 140 centrally confirmed stroke cases and 513 controls.

Interventions  Participants received 0.625 mg/d of conjugated equine estrogen plus 2.5 mg/d of medroxyprogesterone acetate (n = 8506) or placebo (n = 8102).

Main Outcome Measures  Overall strokes and stroke subtype and severity were centrally adjudicated by stroke neurologists.

Results  One hundred fifty-one patients (1.8%) in the estrogen plus progestin and 107 (1.3%) in the placebo groups had strokes. Overall 79.8% of strokes were ischemic. For combined ischemic and hemorrhagic strokes, the intention-to-treat hazard ratio (HR) for estrogen plus progestin vs placebo was 1.31 (95% confidence interval [CI], 1.02-1.68); with adjustment for adherence, the HR was 1.50 (95% CI, 1.08-2.08). The HR for ischemic stroke was 1.44 (95% CI, 1.09-1.90) and for hemorrhagic stroke, 0.82 (95% CI, 0.43-1.56). Point estimates of the HRs indicate that excess risk of all stroke was apparent in all age groups, in all categories of baseline stroke risk, and in women with and without hypertension, prior history of cardiovascular disease, use of hormones, statins, or aspirin. Other risk factors for stroke, including smoking, blood pressure, diabetes, lower use of vitamin C supplements, blood-based biomarkers of inflammation, higher white blood cell count, and higher hematocrit levels did not modify the effect of estrogen plus progestin on stroke risk.

Conclusions  Estrogen plus progestin increases the risk of ischemic stroke in generally healthy postmenopausal women. Excess risk for all strokes attributed to estrogen plus progestin appeared to be present in all subgroups of women examined.

Author Affiliations: Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY (Dr Wassertheil-Smoller); Wayne State University WHI Clinical Center, Detroit, Mich (Dr Hendrix); University of Florida WHI Clinical Center, Gainesville (Dr Limacher); University of North Carolina School of Medicine and Public Health, Durham (Dr Heiss); Fred Hutchinson Cancer Research Center, Seattle, Wash (Drs Kooperberg and Mr Aragaki); National Institute of Neurological Disorders and Stroke, Stroke Neuroscience Unit, Bethesda, Md (Dr Baird); Medical College of Wisconsin, Milwaukee (Dr Kotchen); Women's Health Hawaii, Honolulu (Dr Curb); Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill (Dr Black); National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Rossouw), University of Medicine and Dentistry of New Jersey, Newark (Dr Safford); Medical Research Laboratories, Highland Heights, Ky (Dr Stein); Georgetown Washington University, Washington, DC (Dr Laowattana); and Ohio State University, Columbus (Dr Mysiw).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTER

Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial

JAMA. ;291():1701-1712.
FULL TEXT  

RELATED ARTICLES

Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial
, , , , , , , , , , , , and
JAMA. ;289():2651-2662.
FULL TEXT  

Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial
, , , , , , , , , , , , , and
JAMA. ;289():2663-2672.
FULL TEXT  

Hormone Therapy and the Brain: Deja Vu All Over Again?

JAMA. ;289():2717-2719.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause
Prentice et al.
Am J Epidemiol 2009;170:12-23.
ABSTRACT | FULL TEXT  

Cancer Prevention: From 1727 to Milestones of the Past 100 Years
Lippman and Hawk
Cancer Res. 2009;69:5269-5284.
ABSTRACT | FULL TEXT  

Cardiovascular Effects of Physiological and Standard Sex Steroid Replacement Regimens in Premature Ovarian Failure
Langrish et al.
Hypertension 2009;53:805-811.
ABSTRACT | FULL TEXT  

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis
Doren
Eur Heart J 2009;30:866-867.
FULL TEXT  

Reproductive History, Oral Contraceptive Use, and the Risk of Ischemic and Hemorrhagic Stoke in a Cohort Study of Middle-Aged Swedish Women
Yang et al.
Stroke 2009;40:1050-1058.
ABSTRACT | FULL TEXT  

Stroke in Women: An Evolving Topic
Kurth and Bousser
Stroke 2009;40:1027-1028.
FULL TEXT  

Age at Natural Menopause and Risk of Ischemic Stroke: The Framingham Heart Study
Lisabeth et al.
Stroke 2009;40:1044-1049.
ABSTRACT | FULL TEXT  

Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study
Hsia et al.
BMJ 2009;338:b219-b219.
ABSTRACT | FULL TEXT  

A Select Combination of Clinically Relevant Phytoestrogens Enhances Estrogen Receptor {beta}-Binding Selectivity and Neuroprotective Activities in Vitro and in Vivo
Zhao et al.
Endocrinology 2009;150:770-783.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
WRITING GROUP MEMBERS et al.
Circulation 2009;119:e21-e181.
FULL TEXT  

Postmenopausal hormone therapy and subclinical cerebrovascular disease: The WHIMS-MRI Study
Coker et al.
Neurology 2009;72:125-134.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study
Resnick et al.
Neurology 2009;72:135-142.
ABSTRACT | FULL TEXT  

Reassessing Benefits and Risks of Hormone Therapy
Gass et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2009;3:29-43.
ABSTRACT  

Sleep Duration and Risk of Ischemic Stroke in Postmenopausal Women * Supplemental Appendix
Chen et al.
Stroke 2008;39:3185-3192.
ABSTRACT | FULL TEXT  

Hormone therapy and risk of myocardial infarction: a national register study
Lokkegaard et al.
Eur Heart J 2008;29:2660-2668.
ABSTRACT | FULL TEXT  

Metabolism, Distribution, and Excretion of a Next Generation Selective Estrogen Receptor Modulator, Lasofoxifene, in Rats and Monkeys
Prakash et al.
Drug Metab. Dispos. 2008;36:1753-1769.
ABSTRACT | FULL TEXT  

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis
Sare et al.
Eur Heart J 2008;29:2031-2041.
ABSTRACT | FULL TEXT  

Disposition of Lasofoxifene, a Next-Generation Selective Estrogen Receptor Modulator, in Healthy Male Subjects
Prakash et al.
Drug Metab. Dispos. 2008;36:1218-1226.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone Therapy and Stroke: Role of Time Since Menopause and Age at Initiation of Hormone Therapy
Grodstein et al.
Arch Intern Med 2008;168:861-866.
ABSTRACT | FULL TEXT  

Lipoprotein-Associated Phospholipase A2, Hormone Use, and the Risk of Ischemic Stroke in Postmenopausal Women
Wassertheil-Smoller et al.
Hypertension 2008;51:1115-1122.
ABSTRACT | FULL TEXT  

Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Heiss et al.
JAMA 2008;299:1036-1045.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Writing Group Members et al.
Circulation 2008;117:e25-e146.
FULL TEXT  

Pharmacokinetics and Pharmacodynamics of Drospirenone-Estradiol Combination Hormone Therapy Product Coadministered With Hydrochlorothiazide in Hypertensive Postmenopausal Women
Karara et al.
J Clin Pharmacol 2007;47:1292-1302.
ABSTRACT | FULL TEXT  

Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists
Collins et al.
Eur Heart J 2007;28:2028-2040.
ABSTRACT | FULL TEXT  

Neurocognitive Outcomes Are Not Improved by 17{beta}-Estradiol in Postmenopausal Women Undergoing Cardiac Surgery
Hogue et al.
Stroke 2007;38:2048-2054.
ABSTRACT | FULL TEXT  

Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Schumacher et al.
Endocr. Rev. 2007;28:387-439.
ABSTRACT | FULL TEXT  

Review Article: Vascular and Metabolic Effects of Sex Steroids: New Insights Into Clinical Trials
Wierman and Kohrt
Reproductive Sciences 2007;14:300-314.
ABSTRACT  

Activation of a Membrane-Associated Androgen Receptor Promotes Cell Death in Primary Cortical Astrocytes
Gatson and Singh
Endocrinology 2007;148:2458-2464.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
Rossouw et al.
JAMA 2007;297:1465-1477.
ABSTRACT | FULL TEXT  

Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions
Suzuki et al.
Proc. Natl. Acad. Sci. USA 2007;104:6013-6018.
ABSTRACT | FULL TEXT  

Estrogen, cognition and female ageing
Genazzani et al.
Hum Reprod Update 2007;13:175-187.
ABSTRACT | FULL TEXT  

Calcium/Vitamin D Supplementation and Cardiovascular Events
Hsia et al.
Circulation 2007;115:846-854.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2007;115:e69-e171.
FULL TEXT  

Selective Activation of Estrogen Receptor-{beta} Transcriptional Pathways by an Herbal Extract
Cvoro et al.
Endocrinology 2007;148:538-547.
ABSTRACT | FULL TEXT  

Historical Perspectives in Postmenopausal Hormone Therapy: Defining the Right Dose and Duration
Warren
Mayo Clin Proc. 2007;82:219-226.
ABSTRACT | FULL TEXT  

Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Turgeon et al.
Endocr. Rev. 2006;27:575-605.
ABSTRACT | FULL TEXT  

Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group
Bushnell et al.
Stroke 2006;37:2387-2399.
ABSTRACT | FULL TEXT  

The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-Oophorectomy
Madalinska et al.
JCO 2006;24:3576-3582.
ABSTRACT | FULL TEXT  

Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation
Prentice and QI
Biostatistics 2006;7:339-354.
ABSTRACT | FULL TEXT  

Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial
Vogel et al.
JAMA 2006;295:2727-2741.
ABSTRACT | FULL TEXT  

Differential Modulation of Estrogen Receptors (ERs) in Ischemic Brain Injury: A Role for ER{alpha} in Estradiol-Mediated Protection against Delayed Cell Death
Dubal et al.
Endocrinology 2006;147:3076-3084.
ABSTRACT | FULL TEXT  

Effects of Conjugated Equine Estrogen on Stroke in the Women's Health Initiative
Hendrix et al.
Circulation 2006;113:2425-2434.
ABSTRACT | FULL TEXT  

The WHI and the Postmenopausal Woman: No Magic Bullet
JWatch Women's Health 2006;2006:1-1.
FULL TEXT  

Potentially Inappropriate Prescribing for Elderly Patients in 2 Outpatient Settings
Maio et al.
American Journal of Medical Quality 2006;21:162-168.
ABSTRACT  

Novel Mechanisms for Estrogen-Induced Neuroprotection.
Singh et al.
Exp. Biol. Med. 2006;231:514-521.
ABSTRACT | FULL TEXT  

Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
Resnick et al.
J. Clin. Endocrinol. Metab. 2006;91:1802-1810.
ABSTRACT | FULL TEXT  

Combined Analysis of Women's Health Initiative Observational and Clinical Trial Data on Postmenopausal Hormone Treatment and Cardiovascular Disease
Prentice et al.
Am J Epidemiol 2006;163:589-599.
ABSTRACT | FULL TEXT  

Dismembering the ethical physician.
Genuis
Postgrad. Med. J. 2006;82:233-238.
ABSTRACT | FULL TEXT  

Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke.
Lemaitre et al.
Arch Intern Med 2006;166:399-404.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Thom et al.
Circulation 2006;113:e85-e151.
FULL TEXT  

Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate {alpha}-ENaC and sgk1 expression in renal collecting duct epithelia
Thomas et al.
Am. J. Physiol. Renal Physiol. 2006;290:F306-F312.
ABSTRACT | FULL TEXT  

Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study
Pentti et al.
Eur J Endocrinol 2006;154:101-107.
ABSTRACT | FULL TEXT  

Harnessing Hormonal Signaling for Cardioprotection
Ballard and Edelberg
Sci Aging Knowl Environ 2005;2005:re6-re6.
ABSTRACT | FULL TEXT  

Changes in Women's Use of Hormones After the Women's Health Initiative Estrogen and Progestin Trial by Race, Education, and Income
Wei et al.
J Natl Cancer Inst Monogr 2005;2005:106-112.
ABSTRACT | FULL TEXT  

Effects of Estrogen on Platelet Reactivity After Transient Forebrain Ischemia in Rats
Littleton-Kearney et al.
Biol Res Nurs 2005;7:135-145.
ABSTRACT  

HIV/AIDS prevention in Uganda: why has it worked?
Genuis and Genuis
Postgrad. Med. J. 2005;81:615-617.
FULL TEXT  

Differential regulation of insulin resistance and hypertension by sex hormones in fructose-fed male rats
Vasudevan et al.
Am. J. Physiol. Heart Circ. Physiol. 2005;289:H1335-H1342.
ABSTRACT | FULL TEXT  

Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study
Fang et al.
Circulation 2005;112:1687-1691.
ABSTRACT | FULL TEXT  

Risk of adverse drug events by patient destination after hospital discharge
Triller et al.
Am J Health Syst Pharm 2005;62:1883-1889.
ABSTRACT | FULL TEXT  

The Proliferation of Clinical Practice Guidelines: Professional Development or Medicine-by-Numbers?
Genuis
J Am Board Fam Med 2005;18:419-425.
ABSTRACT | FULL TEXT  

Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the Discrepancy between Observational Studies and the Women's Health Initiative Clinical Trial
Prentice et al.
Am J Epidemiol 2005;162:404-414.
ABSTRACT | FULL TEXT  

Major Risk Factors for Intracerebral Hemorrhage in the Young Are Modifiable
Feldmann et al.
Stroke 2005;36:1881-1885.
ABSTRACT | FULL TEXT  

Does Sex Matter in Musculoskeletal Health? The Influence of Sex and Gender on Musculoskeletal Health
Tosi et al.
JBJS 2005;87:1631-1647.
FULL TEXT  

High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats
Schreihofer et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005;289:R103-R108.
ABSTRACT | FULL TEXT  

Sex, Hormones, and Alzheimer's Disease
Baum
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:736-743.
ABSTRACT | FULL TEXT  

Astrocyte-Derived Transforming Growth Factor-{beta} Mediates the Neuroprotective Effects of 17{beta}-Estradiol: Involvement of Nonclassical Genomic Signaling Pathways
Dhandapani et al.
Endocrinology 2005;146:2749-2759.
ABSTRACT | FULL TEXT  

Menopause, micronutrients, and hormone therapy
Wylie-Rosett
Am. J. Clin. Nutr. 2005;81:1223S-1231S.
ABSTRACT | FULL TEXT  

Are Estrogens Protective or Risk Factors in Brain Injury and Neurodegeneration? Reevaluation after the Women's Health Initiative
Wise et al.
Endocr. Rev. 2005;26:308-312.
ABSTRACT | FULL TEXT  

Use of Hormone Replacement Therapy by Postmenopausal Women After Publication of the Women's Health Initiative Trial
Ness et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:460-462.
ABSTRACT | FULL TEXT  

William M. Feinberg Lecture: Cognitive Vitality and the Role of Stroke and Cardiovascular Disease Risk Factors
Gorelick
Stroke 2005;36:875-879.
ABSTRACT | FULL TEXT  

Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer
Javid et al.
Carcinogenesis 2005;26:587-595.
ABSTRACT | FULL TEXT  

Estrogen Treatment for Urinary Incontinence: Never, Now, or in the Future?
DuBeau
JAMA 2005;293:998-1001.
FULL TEXT  

Time to review all the evidence for hormone replacement therapy
Crawford and Langhorne
BMJ 2005;330:345-345.
FULL TEXT  

Decline in Lung Function in Patients With Lymphangioleiomyomatosis Treated With or Without Progesterone
Taveira-DaSilva et al.
Chest 2004;126:1867-1874.
ABSTRACT | FULL TEXT  

Hormone Therapy: Making Decisions in the Face of Uncertainty
Peterson et al.
Arch Intern Med 2004;164:2308-2312.
FULL TEXT  

Risk Factors for Vascular Dementia and Alzheimer Disease
Gorelick
Stroke 2004;35:2620-2622.
ABSTRACT | FULL TEXT  

Estrogen-Like Compounds for Ischemic Neuroprotection
Simpkins et al.
Stroke 2004;35:2648-2651.
ABSTRACT | FULL TEXT  

Sex, Steroids, and Stroke: Introduction
Hurn and Sacco
Stroke 2004;35:2642-2643.
FULL TEXT  

Risk of ischemic stroke with tamoxifen treatment for breast cancer: A meta-analysis
Bushnell and Goldstein
Neurology 2004;63:1230-1233.
ABSTRACT | FULL TEXT  

Estrogen Plus Progestin and Risk of Venous Thrombosis
Cushman et al.
JAMA 2004;292:1573-1580.
ABSTRACT | FULL TEXT  

Targeting of the Renin-Angiotensin System as an Adjunct to Estrogen Replacement Therapy
Harrison-Bernard
Hypertension 2004;44:390-391.
FULL TEXT  

Effects of estrogen deprivation due to breast cancer treatment
Angelopoulos et al.
Endocr Relat Cancer 2004;11:523-535.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy
Lochner and Einhorn
J Am Acad Orthop Surg 2004;12:291-294.
FULL TEXT  

The Effect of Menopause on Grip and Pinch Strength: Results from the Chicago, Illinois, Site of the Study of Women's Health Across the Nation
Kurina et al.
Am J Epidemiol 2004;160:484-491.
ABSTRACT | FULL TEXT  

A Three-Part Intervention To Change the Use of Hormone Replacement Therapy in Response to New Evidence
Roumie et al.
ANN INTERN MED 2004;141:118-125.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women
Kang et al.
Neurology 2004;63:101-107.
ABSTRACT | FULL TEXT  

Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells
Lee et al.
Cardiovasc Res 2004;63:139-148.
ABSTRACT | FULL TEXT  

Commentary: The hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology?
Lawlor et al.
Int J Epidemiol 2004;33:464-467.
FULL TEXT  

Measuring Hot Flashes: Summary of a National Institutes of Health Workshop
Miller and Li
Mayo Clin Proc. 2004;79:777-781.
 

Fracture Incidence in Relation to the Pattern of Use of Hormone Therapy in Postmenopausal Women
Banks et al.
JAMA 2004;291:2212-2220.
ABSTRACT | FULL TEXT  

Is the Hormonal Fountain of Youth Drying Up?
Morley
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:M458-M460.
FULL TEXT  

Osteogenic regulation of vascular calcification: an early perspective
Vattikuti and Towler
Am. J. Physiol. Endocrinol. Metab. 2004;286:E686-E696.
ABSTRACT | FULL TEXT  

Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial
The Women's Health Initiative Steering Committee
JAMA 2004;291:1701-1712.
ABSTRACT | FULL TEXT  

Commonly Used Types of Postmenopausal Estrogen for Treatment of Hot Flashes: Scientific Review
Nelson
JAMA 2004;291:1610-1620.
ABSTRACT | FULL TEXT